Khan N, Khan A, Umar Z, Muhammad F, Abbas M, Ahmed A, et al. Prospective Evaluation of Atrial Fibrillation Risk in Type 2 Diabetes Comparing SGLT-2 Inhibitors and DPP-4 Inhibitors. IJBR [Internet]. 2025 Mar. 12 [cited 2025 Dec. 12];3(3):69-75. Available from: https://www.ijbr.com.pk/IJBR/article/view/797